Business Name: |
Central Florida Medical Imagin |
Address: |
1053 Med Center Drive # 151, Orange City, Florida 32763 |
Phone Number: |
(972) 542-9419 |
Annual Revenue (USD): |
$50.000 to $99.999 |
Founding Year: |
2010 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Health Services |
SIC Code: |
8099 |
NAICS Code: |
621999 |
Share This Business: |
|
Related Businesses: |
West Volusia Medica Imaging - Orange City, FL 32763 Florida Medical Assoc - Orange City, FL 32763 Advanced Women's Health Spec - Orange City, FL 32763 Discovery Child Care Center - Orange City, FL 32763 Family Health Services & Assoc - Orange City, FL 32763 Permanent Choice Clinic Inc - Orange City, FL 32763 Optimal Healthcare Physical - Orange City, FL 32763 Care Life Outreach Inc - Orange City, FL 32763 Advanced Practice Medical Associates Pllc - Orange City, FL 32763 Central Florida Medical Imaging Pa - Orange City, FL 32763 Commons Medical Development - Orange City, FL 32763 Geri Krista - Orange City, FL 32763 First Care Walk In Clinic - Orange City, FL 32763 Orange Medical Plaza LLC - Orange City, FL 32763 Choices Mental Health Inc - Orange City, FL 32763 Tomoka Medical Lab Inc - Orange City, FL 32763 |
The company Central Florida Medical Imagin provides B2C services in the form of Health Services from its single location in Florida.
1 to 4 employees work for Central Florida Medical Imagin, and the business now earns $50.000 to $99.999 per annum.
Central Florida Medical Imagin was launched in 2010 and is classified under SIC code and category 8099 , and NAICS number and grouping 621999 .
To contact Central Florida Medical Imagin, please call with the phone number (972) 542-9419 or visit its single location at 1053 Med Center Drive # 151 in Orange City, Florida 32763.
The location of the single location can also be found using the coordinates .
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.